Antitumor Drugs
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients (NCT04962425) | Peking University Third Hospital | 2021-01-08 |
| Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab (NCT04961307) | Peking University Third Hospital | 2019-07-05 |
Track Antitumor Drugs automatically
Every clearance here is in the API, with alerts when new ones post.